XML 94 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
REVENUE    
Total revenue $ 11,853,266 $ 10,693,196
COST OF SALES    
Total cost of sales 3,560,624 4,060,034
GROSS PROFIT 8,292,642 6,633,162
OPERATING EXPENSES    
Depreciation expense 20,777 23,132
Selling, general and administrative 3,076,820 2,703,141
Total operating expenses 3,097,597 2,726,273
INCOME FROM CONTINUING OPERATIONS 5,195,045 3,906,889
OTHER INCOME (EXPENSE)    
Other (expense) income (49,795) 150,250
Gain on debt refinance and forgiveness 115,448 1,397,271
Penalties and fees (53,000) (2,063,916)
Interest expense (1,956,266) (6,387,309)
Amortization of debt discounts (136,518) (253,823)
Total other expenses (2,080,131) (7,157,527)
NET INCOME (LOSS) BEFORE DISCONTINUED OPERATIONS 3,114,914 (3,250,638)
LOSS FROM DISCONTINUED OPERATIONS 0 (2,178,883)
LOSS FROM DISPOSAL OF DISCONTINUED OPERATIONS (86,520) 0
LOSS FROM DISCONTINUED OPERATIONS (86,520) (2,178,883)
NET INCOME (LOSS) FOR THE YEAR 3,028,394 (5,429,521)
PREFERRED STOCK DIVIDENDS (780,074) (384,170)
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS $ 2,248,320 $ (5,813,691)
BASIC EARNINGS (LOSS) PER SHARE    
CONTINUING OPERATIONS $ 156 $ (999)
DISCONTINUED OPERATIONS (6) (374)
DILUTED EARNINGS (LOSS) PER SHARE    
CONTINUING OPERATIONS 232 (999)
DISCONTINUED OPERATIONS $ (6) $ (374)
WEIGHTED AVERAGE SHARES OUTSTANDING – BASIC 14,444 5,822
WEIGHTED AVERAGE SHARES OUTSTANDING – DILUTED 15,001 5,822
Health Care [Member]    
REVENUE    
Total revenue $ 11,853,266 $ 10,693,196
COST OF SALES    
Total cost of sales $ 3,560,624 $ 4,060,034